Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orlistat

A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)

Empros Pharma AB · Phase 1/2 · Completed · Enrollment 156

NCT04521751

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.